Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biotricity Inc (NQ: BTCY )

0.8501 -0.0099 (-1.15%)
Streaming Delayed Price Updated: 1:44 PM EST, Nov 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biotricity Inc

< Previous 1 2 3 4 5 6 Next >
Biotricity Reports Financial Results for Fiscal 2022 Fourth Quarter and Full Year
Company Reports Record Revenue and Improved Margins 
From Biotricity, Inc.
Via AccessWire
Exposures COVID-19
12 Health Care Stocks Moving In Tuesday's Intraday Session
  
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Biotricity to Join Russell Microcap(R) Index
REDWOOD CITY, CA / ACCESSWIRE / June 23, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced that the... 
From Biotricity, Inc.
Via AccessWire
Biotricity: Dividend Insights
Tuesday marks the last chance for investors to receive the next dividend payout from Biotricity. What's Happening (NASDAQ: 
Via Benzinga
InflaRx Climbs More Than 40%, Here's 58 Biggest Movers From Yesterday
Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade. 
Via Benzinga
37 Stocks Moving In Thursday's Mid-Day Session
Gainers Advent Technologies Holdings, Inc. (NYSE: ADN) shares jumped 153% to $2.94 after the company announced it received notification of euro 782.1 million of funding from the Greek State for the... 
Via Benzinga
77 Biggest Movers From Yesterday
Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) shares climbed 364% to close at $9.93 on Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 59 stocks hit new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers 
Via Benzinga
Biotricity to Present at the 2022 H.C. Wainwright Global Investment Conference on Tuesday May 24th
REDWOOD CITY, CA / ACCESSWIRE / May 23, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is scheduled to present... 
From Biotricity, Inc.
Via AccessWire
71 Biggest Movers From Yesterday
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation... 
Via Benzinga
Biotricity Issues Shareholder Update
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence. 
From Biotricity, Inc.
Via AccessWire
Exposures COVID-19
Biotricity to Launch Commercial Sales of Its Disruptive Cardiac Monitoring Device, Biotres in April 2022
- Company reports pre-order sales from existing customers of its wireless wearable device for early detection of cardiac arrhythmias REDWOOD CITY, CA / ACCESSWIRE / March 22, 2022 / Biotricity, Inc.... 
From Biotricity, Inc.
Via AccessWire
Exposures Product Safety
Biotricity Inc. (NASDAQ: BTCY) Featured in Virtual Coverage of the 34th Annual Roth Conference
Via Investor Brand Network
Biotricity Named to Fast Company's Annual List of the World's 50 Most Innovative Companies for 2022
Leader in early-detection cardiac diagnostics monitoring solutions joins the ranks of Canva, Microsoft, SpaceX, and more REDWOOD CITY, CA / ACCESSWIRE / March 8, 2022 / Biotricity, Inc. (NASDAQ:BTCY)... 
From Biotricity, Inc.
Via AccessWire
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2022
Upgrades According to Brookline Capital, the prior rating for Intellia Therapeutics Inc (NASDAQ:NTLA) was changed from Hold to Buy. In the fourth quarter, Intellia Therapeutics... 
Via Benzinga
Biotricity, Inc. to Attend 34th Annual Roth Conference March 13th-15th
- Follows fiscal third quarter earnings that saw revenue up 93% year-over-year and Company's highest-ever quarterly cash position - Biotricity now taking preorders for Biotres, an FDA-cleared,... 
From Biotricity, Inc.
Via AccessWire
Biotricity Now Taking Pre-Orders for its Biotres Wireless Wearable Cardiac Monitoring Device
- Announcement follows FDA clearance - Pre-Orders begin on February 23, 2022 with units shipping April 1, 2022 REDWOOD CITY, CA / ACCESSWIRE / February 23, 2022 / Biotricity, Inc. (NASDAQ:BTCY)... 
From Biotricity, Inc.
Via AccessWire
Exposures Product Safety
Biotricity Releases Fiscal 2022 Third Quarter Financial Results
Management to host investor call on Tuesday February 15th at 4:15 pm ET - 93% YOY Revenue Gains to $1.93 Million - Revenue Outpaces SG&A Increase by 2.2x - Cash Position of $16.8 Million at Quarter End... 
From Biotricity, Inc.
Via AccessWire
Biotricity to Report Third Quarter Fiscal 2022 Financial Results on February 14, 2022
Management to host call on Tuesday, February 15th at 4:15pm ET Sees Calendar-2022 as a breakout year with commercial launch of Bioheart and FDA clearance for Biotres REDWOOD CITY, CA / ACCESSWIRE /... 
From Biotricity, Inc.
Via AccessWire
Exposures Product Safety
Earnings Scheduled For February 14, 2022
Companies Reporting Before The Bell • Weber (NYSE:WEBR) is projected to report quarterly loss at $0.06 per share on revenue of $310.78 million. 
Via Benzinga
Biotricity Receives FDA 510(k) Clearance for its Biotres Cardiac Monitoring Device
Biotres is designed to continuously record ECG data for early detection of cardiac arrhythmias The Biotres addresses the $2 Billion-dollar holter market REDWOOD CITY, CA / ACCESSWIRE / January 24, 2022... 
From Biotricity, Inc.
Via AccessWire
Exposures Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Kiora Pharmaceuticals (NASDAQ:KPRX) stock moved upwards by 20.4% to $1.06 during Thursday's pre-market session. The market value of their outstanding shares is... 
Via Benzinga
Biotricity Expands Distribution of New Bioheart Device on Amazon.com
New Heart Monitoring Solution Delivers Personalized Heart Health Insights Directly to Your Smartphone Now Easy to Buy and Use: No Prescription Needed for Advanced Heart and Lifestyle Solution REDWOOD... 
From Biotricity, Inc.
Via AccessWire
Biotricity Completes $12 Million Non-Dilutive Debt Financing
Capital infusion to finance inventory and annual recurring revenue subscriptions replaces expiring debt with more favorable terms 5-year term deal strengthens balance sheet, positions company for... 
From Biotricity, Inc.
Via AccessWire
Biotricity, a Leader in Remote Cardiac Health Monitoring Solutions, Issues Company Roadmap in 2021 Shareholder Letter
The Company believes that it is "well-positioned for 2022." Letter highlights milestones, products roadmap, growth strategy and 2022 goals REDWOOD CITY, CA / ACCESSWIRE / December 7, 2021 / Biotricity,... 
From Biotricity, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Benzinga's Top Ratings Upgrades, Downgrades For November 23, 2021
Upgrades Keefe, Bruyette & Woods upgraded the previous rating for CBRE Group Inc (NYSE: 
Via Benzinga
Choked Telehealth Market: How Do You Choose the Right Product? This Device Might Do Everything
The Prizma G2 device. (Source: G Medical Innovations) The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.